Zobrazeno 1 - 10
of 323
pro vyhledávání: '"Ali, Shamseddine"'
Autor:
Eman Sbaity, Hani Tamim, Ghada El-Hajj Fuleihan, Jaber Abbas, Mariam Zahwe, Razan El Sayed, Ali Shamseddine
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Developing countries have a significantly higher incidence of breast cancer in patients younger than 40 years as compared to developed countries. This study aimed to examine if young age at diagnosis is an independent prognostic f
Externí odkaz:
https://doaj.org/article/fead6fc54311462b91b65c266742579a
Autor:
Walaa Mahmoud, Lara Hassoun, Anthony Kerbage, Deborah Mukherji, Ali Shamseddine, Sally Tamraz, Ayman Hakim, Kassem Barada
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background A high neutrophil-lymphocyte ratio (NLR) may be associated with worse survival in esophageal cancer (EC). Our aims were to describe the demographic and clinical data of EC in a tertiary referral center in Lebanon and to determine
Externí odkaz:
https://doaj.org/article/4bb1a628699c4a4aa7cee3940724a9c1
Publikováno v:
Diagnostics, Vol 14, Iss 22, p 2512 (2024)
Background: Pancreatic cancer is among the malignancies with the poorest prognosis, largely due to its aggressive nature and resistance to conventional therapies. Case Summary: This report describes the case of a 69-year-old male patient with stage I
Externí odkaz:
https://doaj.org/article/d6e4153c79244ed2afc63b5272344542
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Bladder cancer (BC) poses a significant health challenge, particularly in metastatic cases, where the prognosis is unfavorable and therapeutic options are limited. Poly ADP-ribose polymerase (PARP) inhibitors have gained approval for use in various c
Externí odkaz:
https://doaj.org/article/034591b78d3547c788a5da1c82a87810
Publikováno v:
Middle East Journal of Cancer, Vol 14, Iss 4, Pp 550-558 (2023)
Background: Pancreatic cancer is characterized by its generally poor prognosis and ranks seventh worldwide in cancer-related mortality. We previously conducted a prospective study on the use of modified GTX regimen (a combination of gemcitabine, doce
Externí odkaz:
https://doaj.org/article/6061dfe7979a4d4795130c86c16c90a0
Autor:
Alain Abi Ghanem, Tamara El Annan, Nour El Ghawi, Nadine Omran, Mustafa Natout, Hazem Assi, Ali Shamseddine, Nina Saliba, Mohamad Haidar
Publikováno v:
Diagnostics, Vol 14, Iss 15, p 1622 (2024)
Fibroblast Activation Protein Inhibitor (FAPI) positron emission tomography (PET) imaging has emerged as a useful method for identifying pancreatic disorders, notably pancreatitis. Unlike Fluorine-18 fluorodeoxyglucose (FDG), FAPI uptake is directly
Externí odkaz:
https://doaj.org/article/0ec7a1aa71894de19d021ef9ef2a7816
Autor:
Youssef Bouferraa, Yolla Haibe, Hanan Hamdan, Rami Mahfouz, Zaher Chakhachiro, Ali Shamseddine
Publikováno v:
Hematology Reports, Vol 15, Iss 1, Pp 9-16 (2023)
While most cases of thrombotic microangiopathic hemolytic anemias are idiopathic, some can occur in the setting of a malignancy. Differentiating both conditions is crucial to initiate the appropriate treatment. In this case report and literature revi
Externí odkaz:
https://doaj.org/article/58c8ddac83f2408ca2a150e860e27bd3
Autor:
Charbel Elias, Youssef H. Zeidan, Youssef Bouferraa, Deborah Mukherji, Sally Temraz, Maya Charafeddine, Monita Al Darazi, Ali Shamseddine
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Intrahepatic cholangiocarcinoma (CCA) is amongst the most common primary liver tumors worldwide. CCA carries a bad prognosis prompting research to establish new treatment modalities other than surgery and the current chemotherapeu
Externí odkaz:
https://doaj.org/article/c32c3ff7570c44949a968586799e0d37
Autor:
Zeina Ayoub, Jamal Khader, Muhammad Bulbul, Raja B. Khauli, Therese Y. Andraos, Ali Shamseddine, Deborah Mukherji, Fady B. Geara
Publikováno v:
BMC Urology, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background A nadir Prostate-Specific Antigen (nPSA) of 0.06 ng/mL has been shown to be a strong independent predictor of biochemical recurrence-free survival (bRFS) in patients with intermediate or high-risk (HR) prostate cancer treated with
Externí odkaz:
https://doaj.org/article/e576d1bfd1054df6a7e9fa3a3d5c5538
Autor:
Mohamad Haidar, Alain S. Abi-Ghanem, Hicham Moukaddam, Malak El Jebai, Safaa Al Zakleet, Samir Al Rayess, Abdul Rahman Akkawi, Mutaz Kassas, Hani Tamim, Albert El Hajj, Enrique Estrada-Lobato, Medhat M. Osman, Ali Shamseddine
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Biochemical recurrence (BCR) of prostate cancer (PCa) occurs in about 25% of patients treated with radical prostatectomy (RP) and up to 45% in patients who receive external beam radiotherapy (RT). Early diagnosis of PCa recurrence is of high
Externí odkaz:
https://doaj.org/article/0f21e5387bf0418fa562b92bfd338889